Clinicalusedefinition-interaction-example

FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example ClinicalUseDefinition/example-interaction (Narrative)

Biomedical Research and Regulation Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ClinicalUseDefinition.

Generated Narrative: ClinicalUseDefinition

Resource ClinicalUseDefinition "example-interaction"

StructureDefinition Work Group: brr

type: interaction

subject: MedicinalProductDefinition/example

interaction
interactant
item: alphaconazole (interactant#alphaconazole)
interactant
item: betaconazole (interactant#betaconazole)
type: Inhibitor (interactionsType#Inhibitor)
Effects
- Concept
* Increased plasma concentration ()
management: Careful monitoring of dose ()

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.